UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020376
Receipt No. R000023531
Official scientific title of the study Effect of intravitreal triamcinolone injection combined with vitrectomy for proliferative diabetic retinopathy.
Date of disclosure of the study information 2015/12/28
Last modified on 2018/02/05 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effect of intravitreal triamcinolone injection combined with vitrectomy for proliferative diabetic retinopathy.
Title of the study (Brief title) Effect of intravitreal triamcinolone injection combined with vitrectomy for proliferative diabetic retinopathy.
Region
Japan

Condition
Condition Diabetic retinopathy
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine whether intravitreal triamcinolone injection combined with vitrectomy prevent postoperative inflammation and macular edema worsening.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Central retinal thickness (3 days, 1 week, and 1, 3, 6, 12 months after vitrectomy)
Key secondary outcomes Postoperative visual acuity, flare value in anterior chamber, intraocular pressure, and number of intraoperative photocoagulation(3 days, 1 week, and 1, 3, 6, 12 months after vitrectomy)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Triamcinolone acetonide, 4mg, intravitreal injection
Interventions/Control_2 Control group
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) Patients with the document agreement
2) Patients with diabetes mellitus
3) Patients with proliferative diabetic retinopathy who were scheduled vitrectomy
Key exclusion criteria 1) Patients who received intravitreal triamcinolone injection within three months
2) Patients receiving systemic therapy of steroid drugs
3) Patients who was judged to be inappropriate as a subject by doctor in charge
Target sample size 60

Research contact person
Name of lead principal investigator Takehiro Matsumura
Organization Faculty of Medical Science, University of Fukui
Division name Ophthalmology
Address 23-3 Shimoaiduki, Matsuoka, Yoshida, Fukui
TEL 0776-61-8403
Email tmatsu@u-fukui.ac.jp

Public contact
Name of contact person Takehiro Matsumura
Organization Faculty of Medical Science, University of Fukui
Division name Ophthalmology
Address 23-3 Shimoaiduki, Matsuoka, Yoshida, Fukui
TEL 0776-61-8403
Homepage URL
Email tmatsu@u-fukui.ac.jp

Sponsor
Institute Department of Ophthalmology, Faculty of Medical Science, University of Fukui
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 福井大学医学部附属病院(福井県)、信州大学医学部附属病院(長野県)、三重大学医学部附属病院(三重県)、東京医科大学八王子医療センター(東京都)、徳島大学病院(徳島県)、東京女子医科大学糖尿病センター(東京都)

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 28 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 07 Month 27 Day
Anticipated trial start date
2015 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
2018 Year 02 Month 05 Day

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 28 Day
Last modified on
2018 Year 02 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023531